Neoadjuvant Afatinib Based Treatment Strategies Followed by Surgery in Squamous Cell Carcinoma of the Head and Neck: an EORTC NOCI-HNCG Window Study
Phase of Trial: Phase II
Latest Information Update: 15 Jul 2016
At a glance
- Drugs Afatinib (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 06 Jul 2016 Status changed from active, no longer recruiting to completed.
- 16 Jun 2016 This trial is completed in Italy ( end date: 28 Apr 2016).
- 07 Jun 2016 Results of preliminary analysis in patients with newly diagnosed squamous cell carcinoma of the head and neck presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.